Abstract The total cortical and striatal neurone and glial numbers were estimated in five cases of Huntingtoffs disease (three males; two females) and five ageand sex-matched control cases. Serial 500-~tm-thick gallocyanin-stained frontal sections through the left hemisphere were analysed using Cavalieri's principle for volume and the optical disector for cell density estimations. The average cortical neurone number of five controls (mean age 53_+13 years, range 36-72 years) was 5.97 x 109_+320 x 106, the average number of small striatal neurones was 82x 106_+ 15.8 • 106. The left striatum (caudatum, putamen, and accumbens) contained a mean of 273x106_+53• glial cells (oligodendrocytes, astrocytes and unclassifiable glial profiles). The mean cortical neurone number in Huntington's disease patients (mean age 49_+14 years, range 36-75 years) was diminished by about 33% to! 3.99x109_+218x106 nerve cells (P -< 0.012, MannWhitney U-test). The mean number of small striatal neurones decreased tremendously to 9.72 x 106 _+
Introduction
Huntington's disease, a hereditary, autosomal dominant neurodegenerative disorder, is clinically characterized by the triad of motor disturbances, cognitive defects, and emotional disturbances [39] . Neuropathologically, Huntington's disease is diagnosed by bilateral degenerative changes in the striatum [31, 119] and nerve cell loss in this complex and functionally related structures [28, 74, 75, 79] . Vonsattel et al. [120] proposed a simple procedure for the neuropathological grading of caudate atrophy. Myers et al. [86] correlated macroscopical grading of striatal atrophy and reduced nerve cell number with physical disability rating in a large sample of patients. The neurological signs are explained by nerve cell loss in the striate body. Choreic movements in early stages of Huntington's disease are believed to result from inhibition of the subthalamic nucleus [2] by selective degeneration of enkephalin-positive projection neurones directed to the globus pallidus externus [96] , oculomotor disturbances from an interruption in the oculomotor-basal ganglia-thalamocortical circuit [3, 4] , rigidity and bradykinesia from GABA imbalance in the globus pallidus externus/internus transmitter ratio [114] . On the other hand, early stages of Huntington's disease are frequently diagnosed as major depressive diseases, schizophrenia, or personality disorders in psychiatric institutions [39] . Psychiatric signs are known to precede movement disorders by years. The former clinical pictures are less well explained by neuronal degeneration in the striate body. It is argued that atrophy in the striate body disrupts the neuronal loop between prefrontal cortical regions and thalamic feedback [3, 4, 71, 85, 98, 115] . Other investigators explain cognitive deficits by global cortical, subcortical, and white matter atrophy [28, 79] , selective laminar loss of a nonphosphorylated neurofilament (SMI-32 ir) bearing pyramidal cells [25] , and reduced nerve cell density in layers V and VI of the prefrontal cortex [108, 109] . In these investigations, nerve cell density estimations were thought to reflect total neuronal loss. This assumption has been shown to be problematic in ageing research [15, 30, 38, 70] as well as in the calculation of total astroglial number in Huntington's chorea [74] since complex agonal, post mortem, and technical factors are known to influence nerve cell density in an unpredictable manner. These factors cannot be compensated by strict protocols of fixation, embedding, and staining procedures. Therefore, our study is intended to supplement previous quantitative investigations by an unbiased estimation of total hemispheric nerve cell number using Cavalieri's principle for volume and the optical disector for nerve cell density estimation [16, 45, 91, 95, 122, 123] .
Materials and methods
Five brains of patients with the clinical diagnosis of Huntington's disease (two females, three males) and five age-and sex-matched control brains without a history of neurological or psychiatric diseases were fixed in 4 % formalin (one part of commercial 37 % formaldehyde added to nine parts of tap water) for at least 3 months [9, 113] . After removal of the meninges the brain stem and cerebellum were severed at the level of the rostral pons. The plane of section was perpendicular to the longitudinal axis of the brain stem. Both hemispheres were subdivided by a mediosagittal cut and the left hemispheres were pre-treated in ascending concentrations of glycerol-DMSO-formalin mixtures, embedded in gelatine, and soaked again in glycerol-DMSO-formalin mixtures. After these cryoprotective procedures [102] , the embedded hemispheres were deep-frozen in -60~ isopentane and serially sectioned on a Tetrander (Jung, Nussloch) at 600-700 ~m thickness. Section thickness cannot be directly read from the microtome. It must be optically determined in unstained as well as stained sections (for details see [58] ). Due to staining, dehydration, and mounting procedures section thickness linearly decreases by about 20% to 480-540 ~m. The slices were altematingly collected in three plastic boxes and stored in 4 % formalin. For routine and quantitative examinations each third section from the ffonto-parallel series was Nissl stained with gallocyanin. Details of the staining and mounting procedures are given elsewhere [10, 54] . Small tissue samples (maximally 30 • mm) of the first frontal gyrus (Brodmann's area 8), of the head of the caudate nucleus rostral to the anterior commissure, and of the ventral striatum at the level of entrance of the anterior perforating arteries were dissected from the parallel formalin-fixed but unstained serial sections. These tissue segments were dehydrated, paraffin embedded and stained with van Gieson stain [101] and Gallyas' silver impregnation for the demonstration of fibrous astroglia [41] . Slides were coded and diagnosed without knowledge of the clinical history.
An additional unstained thick frozen section was taken at the level of the rostral lateral geniculate body and stained by a modified Gallyas technique [55] to exclude senile changes.
The quantitative composition of serial gallocyanin-stained and parallel unstained sections was determined by point counting methods. For this a transparent square lattice test system [121] , consisting of coarse test lines spaced at 12 mm, was laid upon the unstained and parallel stained sections. Each square of coarse test lines was subdivided by 16 finer test lines spaced at 3 mm. The coarse and fine crossing lines formed the centre points. The number of coarse centre points or hits that fall on to either cortex or white matter yield a simple estimation of the quantitative composition of the cerebral hemispheres. The number of hits or points (Pp) multiplied by the area of the coarse squares (d2=12• mm= 144 mm2), the section thickness, and the factor k yield the volumes of cortex and white matter of unstained and gallocyanin stained cerebral hemispheres. The factor k indicates the spacing of serial sections. It was three in Our investigation since we used every third section for the quantitative analysis.
The volume of stained hemispheres divided by the volume of unstained hemispheres yields the shrinkage factor (sf). Nerve cell density of stained sections multiplied by the shrinkage factor yields the nerve cell density of the fresh volume (or in vivo nerve cell density) assuming reversal of initial swelling of the nervous system after prolonged (at least 3 months) formalin fixation [9, 113] .
The volumes of subcortical structures including striatum, ctaustrum, nuclear complex of thalamus, and amygdaloid bodies were likewise estimated. The number of hits of crossing points of the fine lines was used for analysis of the subcortical nudear volume. Note that d 2 in this case is 3x3=9 mm 2.
To obtain the total cell number within a reference volume (cortex or subcortical nudei), the average nerve cell density must be multiplied by the volume of the cortex or subcortical nuclei. Braendgaard et al. [16] proposed a simple procedure to obtain an unbiased estimation of nerve cell density in the human cerebral cortex. In analogy with Braendgaard et al. [16] each fourth gallocyanin-stained section was centred onto a circle. This circle was subdivided by 30 beams (numerated clockwise from 0-29) radiating at angles of 12 ~ from the centre of the circle. A random number between 0 and 29 was generated by a computer program and the course of the beam, e.g. 5, running through the cortex was marked by ink on the microscope slide. The ensuing section was likewise centred onto the circle and the course of the next beam, in this case 6, penetrating the cortex was traced by ink on this microscope section. The procedure was repeated going clockwise from 5 to 29 or, in larger brains, continuing the cycle from 0 passing all beams of the circle. Thus, a helical, systematically random probing of nerve cell density is achieved. Neo-, periarchi-, and archicortical regions were analysed without further subdivision.
The cortical nerve cell density was determined at higher magnification. A combination of a high power (Planapo oil immersion 40/1.0) objective and a 5x5 mm ocular grid subdivided by 10x10 lines inserted into a widefield (10x) eyepiece were used. A random number 1, 2 or 3 was generated by a computer program. If random number 1 was selected, we started nerve cell density determinations in the molecular layer. Going strictly parallel to the ink line painted onto the microscope slide the visual field was moved 0.375 mm into the cortex and the nerve cell number was counted again. This procedure was repeated until the visual field fell outside the cortical boundaries. If random number 2 appeared, the visual field was moved 0.125 mm below the pial surface and nerve cell number counting was started in layer II. The visual fields were then moved by 0.375-mm intervals through the cortex until the visual field fell into the medullary layer. For random number 3, the visual field was shifted by 0.25 mm into the cortex (or upper layer III) prior to nerve cell density counting. Nerve cell density of the adjoining deeper parts of the cortical ribbon were counted at 0.375-mm intervals identical to the procedures described above. Depending on the random number, the starting points of nerve cell density counting were systematically permutated from 1, 2, 3, 1, 2, 3 ..., 3, 1, 2, 3, 1, 2 ... or 2, 3, 1, 2, 3, 1 ... following individual beams penetrating the cortex. These procedures guarantee a homogeneous unbiased estimation of nerve cell densities. At variance with Braendgaard et al. [16] who had to re-embed, cut, and stain wedges from their 7-mm cortical slabs, we could record nerve cell density directly from our 0.48-to 0.54-ram-thick gallocyanin-stained sections without further histological processing.
Nerve cell density was obtained with the optical disector. This method allows an unbiased estimation of cell densities [16, 45, 91, 95, 122, 123] . We counted all neuronal nucleoli of large nerve cells or all neuronal nuclear profiles of small nerve cells (Qi), respectively, that came anew into the visual field (F~) after focusing on superficial parts of the sections. For this purpose, the fine adjustment knob of the microscope was mechanically stopped after optically penetrating the section for 29.7 ~tm. An average of 250 optical fields with an average of 700 neuronal profiles per case were counted. The quotient Qj/Fi yields the average nerve cell density.
Granule cells were distinguished from cortical astrocytes by their oval nucleus and the presence of a small basophilic cytoplasm. Nevertheless, it was not always possible to decide whether a nuclear profile belonged to a reactive astrocyte, to a small layer II or layer IV granule cell, or to an otherwise unspecified interneurone. These nuclear profiles were recorded as unidentified cell types.
Nerve cell density in the striatum was counted by a slightly different procedure. Pairs of random numbers 1-4 or 0-3 were generated by a computer program. These random numbers were associated with the axes O f an imaginative Cartesian system, the yaxes (random number 0-3) of which ran parallel to the ventricular surface of the caudate nucleus. The x-axes (random number 1-4) pointed in medio-lateral direction (Fig. 1) . If random number pairs 0/1 were selected, nerve cell density was counted in the dorsomedial part of the caudate nucleus. After this, the mechanical stage of the microscope was parallelly moved 2 mm on the x-axis. If the visual field was within the boundaries of the caudate nucleus, nerve cell density was again determined, if not, the mechanical stage was moved an additional 2 mm in lateral direction until the visual field hit either striatal cell bridges or neurones of the dorsomedial putamen. In the absence of the putamen, the mechanical stage was moved 2 mm ventrally and then 2 mm medially until the microscope field fell within the caudate boundaries. These mediolateral and dorsoventral 2-ram steps provide a Table 1 Summary of clinical data and neurological signs pletely devoid of neurones. Numerous tenuous fibre bundles are piercing both striatal nuclei. At variance with the normal controls, these fibre bundles contain an abundance of intensely basophilic oligodendrocytes that render these bundles visible at low-power magnification. Cell density in the nucleus accumbens (Acc) is less reduced than in the dorsal parts of the stfiatum. Bar=l mm systematic random probing of visual fields within the striatal components of one section. In the subsequent section, the coordinates of the starting point were enhanced by one (1/2 instead of 0/1) and neurone density was counted similar to the procedure described above. These steps were repeated until random number pairs 0/4 were achieved after four consecutive sections. In the fourth section, the sampling cycle was started again at the dorsomedial parts of the caudate nucleus. This sampling scheme provides an unbiased cell density estimation throughout the striatum.
Nucleoli of small striatal neurones were counted with the optical disector described above using the same objective/eyepiece combination. Nuclear profiles of astrocytes were recognized by their fine, evenly distributed heterochromatin granules. Nuclear profiles of oligodendrocytes were smaller than astrocytic profiles, frequently clustered either within fibre fascicles or encountered as perineuronal satellites. Nevertheless, a precise classification of glial cells was impossible in gallocyanin stained sections. Equivocal profiles were assigned unidentified cells in Table 4 .
The precision (see CENi, Table 4 ) of the quantitative procedure can be calculated from Pi, Qi and Fi of the individual serial sections [124] . Selected data were subjected to Mann-Whitney Utests at the "Rechenzentrum der Universitfit Wtirzburg".
Results

Clinical data and course of the disease
The clinical data as well as onset and duration of overt neurological signs are summarized in Table 1 that forced him to resign from his job. Memory disturbances were noticed in the oldest of our cases, whereas the symptoms of the 36-year-old female had originally been diagnosed as schizophrenic.
Routine neuropathology
Arteriosclerotic changes were absent from larger penetrating and subcortical arteries in the control and Huntington's disease cases. Some penetrating arteries within the ventral putamen and the rostral globus pallidus externus exhibited increased basophilia of their muscular layer in gallocyanin-stained sections. These phenomena were observed in both Huntington's disease and control cases. Excessive fibrosis of cerebral arterioles was not encountered either in the 72-year-old male Huntington's or in the 75-year-old control case. Alzheimer's neurofibrillary tangles, senile or amyloid plaques were not present either in the controls or in the cases with Huntington's disease. The coded sections through the basal ganglia from Huntington's disease could be unequivocally diagnosed by a marked increase of fibrous astrocytes in Gallyas-stained sections and by a considerably decreased density of small striatal neurones (Figs. 1, 2 ). Although Economo and Koskinas [33] did not mention a welldeveloped layer IIIc in their monograph, isolated large IIIc pyramidal neurones are described in the English translation [32] . These cells form a clear-cut row in thick gallocyanin-stained sections (thin arrows) separated by a cell-poor cleft from layer IV.
Bar= l mm
Laminar pathology in thick frozen gallocyanin-stained sections (Fig. 5 ) was subdivided by numerous tertiary gyri. In our experience, heavy brains are frequently well gyrated and are covered by a thin expanded cortex, whereas in less-well gyrated brains the cortices are thicker. Furthermore, the cortical shrinkage factor was 0.53 in the control case and 0.49 in the patient with Huntington's disease (Table 2) . These fundamental differences in gross anatomy in association with technical factors render assessment of cortical thickness difficult. The row of layer IIIc pyramidal cells is absent and layer IV together with superficial layer V pyramidal cells (thin arrows) is prominent in temporal association fields of Huntington's disease patients. Both corrected cortical volumes were nearly identical (Table 2) Cytoarchitectonically, primary sensory fields are characterized by thin, cell-rich cortical ribbons. The term koniocortex is used to express granularisation of neutones in layers II to IV. Layer Vb is cell sparse and layer VI thin and well demarcated (Fig. 3) . These primary sensory fields comprising Brodmann's areae 3, 1, 2, 41, and 17 were heavily afflicted by conspicuous nerve cell loss in layers III and VI (Fig. 4) . Only few, unusually large pyramidal cells were spared in layer III of the primary sensory fields. Neurones in layers IV and Va appeared resistant to cell degeneration and these layers formed a basophilic cell band separating the pale supraand infragranular layers. In the human neocortex, primary sensory fields are surrounded by an excess of associational fields. At low power microscope investigation, the neocortical ribbon of associational fields appeared remarkably well preserved in Huntington's disease cases. The border between lamina IV and superficial lamina V was more pronounced in most fields of the cortical lobes of cases with Huntington's disease than in matched controls. The overall cortical thickness was reduced in all cases with Huntington's disease, and the supragranular layer was less chromophilic due to a slight to intermediate loss of neurones. An increase of astroglial cells, which blurs in our experience the laminar boundaries in a highly characteristic manner, was not noted. After careful examination of the temporal (Brodmann's [18] areas 20 and 21; yon Economo and Koskinas' [33] fields TE2 and TEl) and parietal (Brodmann's areas 7, 40, and 39; von Economo and Koskinas' fields PE, PF, and PG) neocortex a nearly complete absence of layer IIIc pyramids was noted (Figs. 5, 6 ). The assessment of IIIc neuronal depletion was difficult to accomplish due to the irregular convolution of the respective hemispheric gyri, interareal differences and probable interindividual differences. In most cortical fields, a few, widely Table 3 Summary of corrected cell densities (cm -3) and glial index. Cortical and small striatal neurone density multiplied by volumes of stained cortex and striatum, respectively (Table 2) , yields total neurone numbers in cortex and striatum. Due to rounding errors these products differ from data given in Table 3 Volumes of cortex, subcortical nuclei and white matter, uncorrected and corrected cell densities and glial index
The mean volume of the stained left cortex in Huntington's disease was by 26.7 % lower than the corresponding cortical ribbon in the five control case ( Table 2 , P ---0.012). Point counting in gallocyanin-stained serial sections of cerebral hemispheres and point counting in parallel, formalin-fixed unstained sections provide data on tissue shrinkage of our frozen sections during histological procedures. The shrinkage factor Sfoortex represents the volume ratios of the stained cerebral cortex divided by the volume of the unstained cortex (Table  2) . Likewise, the volume ratios of stained and unstained white matter as well as stained and unstained subcortical nuclei yield shrinkage factors of the white matter and subcortical nuclei including striatum, thalamus, globus pallidus, and amygdala, respectively (Table 2 , Sfwhitte matter, Sfstriatum)" The shrinkage factors of white matter differed considerably from that of the cortex, the means of the cortical and striatal shrinkage factors differed by less than 10 %, but individual shrinkage factors may also diverge considerably. Multiplication of neurone densities by shrinkage factors of the containing space (cortex, striatum) yields corrected cell densities ( Table 3 ). The glial index is the quotient from striatal glial densities and striatal neurone densities (Table 3) . It was 3.35 in controls and nearly seven times higher in Huntington's disease (Table 3) .
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Total nerve cell number in Huntington's disease
Reduced cortical neurone number in Huntington's disease
The mean total nerve cell number in the left cerebral cortex of Huntington's disease patients was 3.99 x 109_+218 • 106 neurones (Table 4) . This number represents a mean 33 % deficit compared with the ageand sex-matched controls, where the left cerebral cortex contained an average of 5.97 • 109_+321 • 106 neurones. The total nerve cell number in control cases was invariably higher than in cases with Huntington's disease patients (Mann-Whitney U-Test, P _< 0.012).
The distinction between small granule and astroglial cells was not always possible in gallocyanin-stained section. Equivocal nuclear profiles were recorded as unidentified cortical cells. Their average number was 573 x 106_+ 123 • 106 in controls and 605 • 106___95 x 106 in Huntington patients (Table 4) . These means did not differ significantly (Mann-Whitney U-test P --_< 0.53).
Decreased striatal nerve cell number
The conspicuous striatal atrophy was associated with a tremendous decrease of small striatal neurones. The average number of small striatal neurones in controls was 82X106-F15.8X106 versus 9.72X106_3.64X106 in Huntington's disease cases. An enormous individual variability could be observed. A maximal number of 13.65 x 106 striatal cells was found in a 72-year-old Huntington patient and a minimal number of 5.46x 106 striatal neurones in 41-year-old male with Huntington's disease (Mann-Whitney U-test P -< 0.012). 
Correlation of total cortical with total striatal neurone number
In our control sample of five cases, striatal neuronal number (Y) correlated negatively with the total cortical neurone number (X). This statistically non-significant correlation was expressed by the equation Y = -3.9131124 • 10 -2 • X-t-315.79 x 10 6 with Spearman' rank correlation coefficient 9 = -0.700, P -< 0.19.
In the five cases with Huntington's disease, striatal number (X) correlated positively with total cortical neurone number (Y), although statistically less significant (9 = 0.300, P ---0. 
Neuroglia
The mean number of astrocytes, oligodendrocytes, and unidentified glial cells was higher in the control cases (Table 4 ). In Huntington's disease, the majority of astroglial nuclei were considerably enlarged and the astroglial perikaryon contained numerous fine lipofuscin granules. Astroglial cells could well be distinguished from oligodendrocytes in Huntington's disease, whereas in the controls the distinction was based mainly on size differences and remained arbitrary.
Discussion
Methodological considerations
Our quantitative results of reduced cortical nerve cell number in Huntington's disease patients substantiate qualitative observations [5, 19, 20, 40, 46, 80, 83, 99, 116] and extend previous quantitative investigations on cortical atrophy [28, 74, 75, 79] and reduced nerve cell density [25, 53, 108, 110] .
The overall 33 % decrease in total neurone number results from a combined decrease of cortical volume and decreased neurone density (Tables 2 and 3) . Cortex, subcortical nuclei, and white matter of individual brains are prone to considerably divergent shrinkage factors (Table 2 ). Therefore, neurone or glial densities (or reconstruction of cell size) must always be corrected with individual as well as tissue-specific shrinkage factors to obtain fresh volumes that reproduce cell densities or cell sizes in unfixed (in vivo) tissue [69] . By calculating total cell number these factors are eliminated. To our knowledge, the present data together with a preliminary report [56] are the first estimations of total neuronal cortical number in Huntington's disease patients. Total nerve cell number in both hemispheres was estimated to range from 10 •215 neurones [49] [50] [51] . These results are in agreement with our estimations of an average of 5.97 • neurones in one hemisphere but our and Haug's data are only half the number given by other authors [16, [89] [90] [91] . This is difficult to explain since our stereological procedures were nearly identical to those applied by Braendgaard et al. [16] . One explanation could be the classification of cellular profiles in gallocyanin-stained preparations. Sometimes, we found it difficult to distinguish astroglial nuclei from small neocortical layer II and layer IV granule cells. Equivocal profiles were quantified as unidentified cell types in Table 4 . This uncertainty was the main reason for abandoning glial counting in the cerebral cortex. Braendgaard et al. [16] used the Giemsa stain in their investigation. This mixture could probably stain perikarya that were only weakly or not at all stained by gallocyanin. At variance with our protocol, Braendgaard et al. [16] estimated the volume of the human prosencephalon in unstained 5-mm-thick frozen sections. The nerve cell density was estimated after embedding small cortical wedges in glycol methacrylate. Braendgaard et al. [16] observed up to 15 % tissue shrinkage after glycol methacrylate embedding, but they did not correct the nerve cell density estimations. Finally, Braendgaard et al. [16] removed the medullary layer prior to glycol methacrylate processing. Layer VIb is known to have uncertain boundaries with the underlying medullary layer outside primary sensory fields. Exclusion of deep layer VI with its very low neuronal density could introduce a bias in average nerve cell density estimations and result in overestimation of total nerve cell number. On the other hand, our uncorrected nerve cell densities (Table 3) are nearly identical to those of Braendgaard et al. [16] .
According to Schr6der et al. [107] the total number of small striatal neurones is ll0xl06 in males and 105N 106 in females. These data were derived from a total of 13 individuals, 9 males and 4 females, ranging in age from 19 to 99 years. In a subsequent study, Lange et al. [74] reported 97.8• microneurones in the striatum of 6 males and 98.7x106 neurones in the striatum of 8 females. In 5 cases of Huntington's disease, Lange et al. [74] observed a 92.4 % decrease of microneurones to an average of 7.42x106. The total number of small striatal cells in these previous investigations is about 20 % higher than in our control cases and 24 % less than in our Huntington's diseases subjects. This difference is most likely due to different approaches in counting and sampling as well as individual differences in striatal neurone number (see also Table 3 ). Schr6der et al. [107] recorded the nucleolar number of small striatal neurones at 375-fold microscopic magnification. In our experience, even using an oil-immersion objective, heterochromatin granules can be confused with nucleolar profiles. In addition, nerve cell density was exclusively estimated by Schr6der et al. [107] in intermediate parts of the putamen, whereas we were meandering through all parts of the striatum, the caudate nucleus as well as the ventral striatum and nucleus accumbens (Fig. 1) .
Lange [75] calculated a total striatal glia number of 422. 5 • cells in six females and eight males. This mean number is considerably higher than our estimation (272.7 x 106 cells, including unidentified cells, Table  4 ). The same holds true for total glia number in Huntington's disease. We found 193 • 106 glial together with unidentified cells in the striatum of Huntington's disease patients (Table 4) , Lange [75] reported 363x 106 glial cells in five Huntington patients. Lange [75] did not mention correction procedures that have a great impact on nuclear instead of nucleolar profile counting in 20-~tm-thick paraffin sections. Nevertheless, our data confirm the observation of Lange et al. [74] of a reduced total astroglia number in Huntington's disease despite the drastically increased glial density in the visual field. The glial index, the ratio of glial cells per neurone, is nearly identical to the number reported by Schr6der et al. [107] . This ratio increased markedly to 22.6 glial cells per neurone in Huntington's disease (Table 3) .
to demonstrate conspicuous astroglial proliferation in the prefrontal cortex of Huntington's disease patients [108] . Our results are in agreement with the neurochemical investigations of Ellison et al. [35] , who found reduced glutamate but unchanged GABA concentrations in the frontal, parietal, and occipital lobes. Almost all smooth nonpyramidal cells (neurones with short axons and sparsely spiny dendrites) are GABA-ergic [29] and perhaps these spared cells render layer IV/V more distinct in Huntington's disease (Figs.  4, 6 ). Reynolds and Pearson [97] , on the other hand, reported decreased glutamate as well as GABA concentrations in the temporal lobe of Huntington's disease patients. Differences in the topography as well as differences in clinical staging could contribute to these discrepancies.
Pathoarchitectonics and functional considerations
Laminar and areal versus diffuse nerve cell loss
The total nerve cell number was investigated in five terminal cases of Huntington's disease. The average deficit in neurone number of 33 % observed in our Huntingtoffs disease patients (Table 4) is a consequence of a long-lasting process afflicting cortical as well as subcortical structures. Nevertheless, neuronal degeneration was not uniformly distributed over the cerebral cortex and its laminae. Primary sensory areas including Brodmann's areae 3, 1, 2 (Fig. 4) , area 17, and area 41 exhibited a conspicuous neuronal depletion of the supragranular layers. This contrasts with subtle changes in the temporal association fields comprising areas 20, 21 (Fig.  6) , and parietal association fields. In our preparations, these fields were characterized by the nearly complete disappearance of IIIc pyramidal neurones with a few widely dispersed large pyramidal cells spared. Neuronal loss in prefrontal and premotor fields appeared intermediate between primary sensory and parietal as well as temporal fields. Thus, our results are congruent with reports of an overall reduced nerve cell density [108] , selective loss of pyramidal neurones containing a nonphosphorylated neurofilament reactive to a monoclonal (SMI-32) antibody [25] , reduced nerve cell density in layers V and VI [108, 109] , and probable hypertrophy of a subset of pyramidal neurones [109] . One conspicuous feature in low-power microscopic inspection of serial frontal sections was a clearly demarcated layer IV in isocortical fields. This phenomenon, which is rather diagnostic in our experience, has been interpreted differently. Vogt and Vogt [119] regarded the pronounced layer IV to be due to laminar accumulation of astroglia cells. In citing K61pin (1912), Brodmann [18] suspected disturbed neocortical development (Vitium primae formationis) in Huntington's disease. We think this phenomenon is due to the degeneration of layer Va pyramidal cells and a subsequent closer spacing of layer IV granule cells. A recent quantitative investigation failed
The psychiatric and neurological pictures of Huntington's disease have mainly been explained by neuronal depletion in the striatum and affliction of cortico-basal ganglia-cortical circuits [22, 26, 39, 48, 81, 82, 112, 128] . Decreased laminar as well as area-specific neurone number represent additional factors to be considered in the pathophysiology of Huntington's disease. Selective loss of layer III, V, and VI pyramidal neurones may be due to retrograde degeneration after death of small spiny striatal neurones that are the major targets of cortical projection cells [6, 37, 43, 65, 66, 84, 88] . These retrograde phenomena could explain nerve cell loss in frontal, parietal, occipital, and temporal association cortices. At variance with previous conclusions that favoured a restricted topographical pattern of corticostriatal projections [68] , recent investigations demonstrated a widespread longitudinal termination of frontal, parietal, occipital, and temporal lobe pyramidal neurone efferents in the caudate nucleus [36, 42, 43, 65, 72, 78, 94, 103, 111, 118, 127] . On the other hand, the primary visual area of monkeys has few, if any, direct connections with the caudate nucleus and ventral putamen [103] . Furthermore, the projection of primary sensory areas to the caudate nucleus are faint in monkeys [73] . It is generally agreed that the caudate nucleus is primarily afflicted in Huntington's disease. These observations favour additional mechanisms of cortical neuronal death besides retrograde degeneration. In addition, electrophysiological observations in early stages of Huntington's disease suggest an early affliction of primary somatosensory fields [1, 34, 62, 87, 117] . Josiassen et al. [67] described visual as well as auditory deficits in asymptomatic offsprings of Huntington's disease patients. These stages exhibit slight or absent striatal degeneration in post-mortem [86] and NMR studies [44] . Therefore, we interpret the marked laminar nerve cell loss in areas 1-3, 17, and 41 as terminal stages of an early-onset cortical neuronal degeneration.
Neuronal depletion has been reported in other neu-ropsychiatric diseases including Alzheimer's and Pick's disease. In the latter, marked striatal degeneration has frequently been described [77] . At variance with Huntington's disease, Pick's disease is characterized by progressive neuronal degeneration from layer II to III to V in the frontal and temporal lobes [24, 61, 64, 106] , whereas Lange [75] pointed to a marked atrophy of parietal and occipital lobes in Huntington's disease. Layer III and layer V of temporal areas 21 and 22 are prone to synapse loss in Alzheimer's disease [105] and a subset of pyramidal cells in layers III and V appears to be afflicted by senile processes and preferentially lost in this disease and in HIV encephalopathy [7, 14, 23, 27, 52, 59, 60, 76, 125] . Taken together, these observations show laminar and areal similarities as well as differences of nerve cell degeneration in Huntington's, Pick's and Alzheimer's disease, and in virus-induced dementia. Nevertheless, a coherent morphological explanation of clinical phenomena in these major neurodegenerative diseases is presently not possible. Diffuse cortical nerve cell loss is insufficient to explain dementia. In a preliminary study [56] we found 4.4x109 cortical neurones with considerable astrogliosis in a non-demented 72-year-old male. The cortex in this case contained only about 108 neurones more than the least affected cortex in a 54-year-old female patient with Huntington's disease (Table 4) . Senile and amyloid plaques were absent in this 72-year-old male. Reinvestigation of the clinical records revealed that the patient had suffered from severe arteriosclerosis and had both thighs amputated.
In Huntington's disease, besides the involvement of subcortical grisea, allocortical regions are invariably affected in the course of the illness. Interestingly, the laminar pathology of the entorhinal region in Huntington's disease differs markedly from Alzheimer's disease. The pre-alpha layer exhibits massive neurofibrillary tangles in Alzheimer's disease [8, 11, 47, 63, 93, 100] , whereas the pre-beta and pri-layers are attenuated in Huntington's disease [12, 13, 57] . The latter laminae are known to connect hippocampal with neocortical fields [126] . Neuropsychological tests have been claimed to distinguish memory deficits found in Huntington's disease from those seen in Alzheimer's disease [17, 21, 92, 104] .
In conclusion, sub-, neo-and allocortical regional and laminar neuronal degeneration in Huntington's disease represents a challenge towards a combined clinicalmorphological approach in unravelling the pathophysiology of this disease and the function of the human CNS in general.
